We observed that while aPKCι was highly expressed, aPKCζ expression was very reduced at the mRNA (Supplementary Figure 1A) and protein (Fig. 1a, Supplementary Figure 1B) levels in CD34+ cells from CML patients and healthy donors. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.